Australia Stock Exchange release from BOTANIX PHARMACE : Botanix receives $2.75m R&D Tax Incentive Refund
27/03/2022 22:22
Australia Stock Exchange release from BOTANIX PHARMACE BOT.AX : Botanix receives $2.75m R&D Tax Incentive Refund
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million